In yesterday’s Wall Street session, Danaher Corp. (NYSE:DHR) shares traded at $250.41, down -1.07% from the previous session.
DHR stock price is now 0.68% away from the 50-day moving average and 9.74% away from the 200-day moving average. The market capitalization of the company currently stands at $185.44B.
With the price target maintained at $280, HSBC Securities recently Upgraded its rating from Hold to Buy for Danaher Corp. (NYSE: DHR). On January 24, 2024, Barclays Downgraded its previous ‘Overweight’ rating to ‘Equal Weight’ on the stock keeping its target price maintained at $240, while ‘HSBC Securities’ rates the stock as ‘Hold’
In other news, Raskas Daniel, SVP – Corporate Development sold 23,757 shares of the company’s stock on Feb 26 ’24. The stock was sold for $5,986,764 at an average price of $252.00. Upon completion of the transaction, the SVP – Corporate Development now directly owns 38,102 shares in the company, valued at $9.54 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 15 ’24, Director LOHR WALTER G sold 3,289 shares of the business’s stock. A total of $826,032 was realized by selling the stock at an average price of $251.15. This leaves the insider owning 14,129 shares of the company worth $3.54 million. A total of 8.82% of the company’s stock is owned by insiders.
During the past 12 months, Danaher Corp. has had a low of $182.09 and a high of $259.00. As of last week, the company has a debt-to-equity ratio of 0.36, a current ratio of 1.85, and a quick ratio of 1.51.
According to the Diagnostics & Research Company, earnings per share came in at 2.05, beating analysts’ expectations of 2.01 by 0.04. This compares to $0.28 EPS in the same period last year. The net profit margin was 16.78% and return on equity was 8.47% for DHR. The company reported revenue of $5.8 billion for the quarter, compared to $5.95 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.57 percent. For the current quarter, analysts expect DHR to generate $5.66B in revenue.
